PHYSIO PS AUTONOMIC MONITORING
The Physio PS, Inc. P&S Monitoring technology is used by physicians and medical providers to non-invasively monitor the Autonomic Nervous System, specifically the Parasympathetic & Sympathetic (P&S) Nervous Systems, both Independently & Simultaneously using an algorithmic measurement of the LFa & RFa.
This advanced P&S Monitoring technology can detect autonomic dysfunction, autonomic neuropathy, as well as underlying illnesses that aren’t as easily detected by existing technology on the market today…This assists in the prevention, diagnosis, and treatment of people (90M+ in the US alone) with Autonomic Dysfunction from a variety of causes, including the diagnosis and treatment of people suffering post-Covid symptoms.
Our technology is able to provide physicians more information to improve their assessment and prioritize therapy planning for a broad spectrum of diseases such as heart disease, hypertension, diabetes, depression, anxiety, COPD, orthostatic intolerance, syncope, exercise intolerance, disorders of the brain (e.g. brain injury, including concussion) and nervous system (e.g., MSA, Alzheimer, Parkinson’s), sweating abnormalities, hormone imbalances, and early detection of sepsis.
Physio PS, Inc. P&S Monitoring Can Improve Outcomes
Physio PS provides unprecedented insight into the physiological responses of the autonomic nervous system.
In general, Parasympathetic and Sympathetic (P&S) Monitoring helps to diagnose and treat patients; enhancing the ability to return health and establish wellness. Once wellness is established (or if the patient was well to begin with), P&S Monitoring helps to maintain wellness and prevent dysfunction, disorder, and disease.
P&S Monitoring Helps to Diagnose.
Most chronic diseases involve at least one of 4 autonomic dysfunctions. Classified as high or low Parasympathetic (P), or high or low sympathetic (S); at rest or when challenged. Restoring or establishing P&S balance (i.e., normalizing Sympathovagal Balance (SB) at rest, or returning proper coordination upon challenge) reduces the individual’s morbidity and mortality risk, as well as the number of co-morbidities. Once the P&S nervous systems are properly balanced, both at rest and coordinated upon challenge, any remaining symptoms are due to end-organ effects. These symptoms may now be more aggressively treated.
P&S Monitoring Helps to Treat.
With the additional information from P&S Monitoring, more specific and individualized therapy plans may be developed. Some diagnoses maybe either parasympathetically-mediated or sympathetically mediated, yet both mediations lead to the same set of symptoms.
Most cardiology patients have P&S dysfunction.
Ultimately, heart failure or a heart attack are end-points doctors and patients alike wish to avoid. The risk of these endpoints is foreshadowed by P&S monitoring which can detect when the nervous system is no longer communicating with the heart appropriately (known as autonomic neuropathy), placing the patient at risk for adverse endpoints.
P&S information is reproducible and appears to be the most appropriate for many patients for risk stratification and follow-up of pharmacological and non-pharmacologic therapy.
About 5 million of the 18 million people with diabetes in the United States don’t even know they are diabetic!
Early detection and treatment of diabetes is important to keep people with diabetes healthy. It can be a major factor to help to reduce the risk of serious complications such as premature heart disease and stroke, blindness, limb amputations, and kidney failure.
Preventive Health starts with P&S Monitoring.
Physio PS can be easily used by anyone as a means of supporting effective healthcare practices. Many people suffer from chronic conditions that overwhelm their daily activities or they get diseases repeatedly, which ultimately raises health insurance premiums. Physio PS technology could detect potential chronic diseases that can be prevented.
Headaches are the body’s warning sign.
The assessment of the productivity and function of the autonomic nervous system using the data that P&S Monitoring with Physio PS, Inc. provides, a healthcare professional can better determine the root of the person’s headaches and have increased insight to help the patient return to a much more pleasant quality of life…
P&S Monitoring can expedite the feelings of improvement while tackling the root cause of anxiety.
Anxiety disorders are the most common mental illness in the United States, affecting as many as 40 million people over the age of 18. That is a staggering 18.1% of the population every year! With the uptick in mental health awareness, and the increased spread of information, this number is sure to grow exponentially.
Better pain management to improve the quality of life.
The Physio PS, Inc. P&S Monitoring technology has the ability to actually quantify pain, as well as the ability to provide conclusive data to gauge the relief that a person has from a given treatment. Physio PS gives the provider or caregiver the ability to understand, using clinical data, how a person’s pain level is or is not responding to treatment. It will also show if a person is not in physical pain, allowing for proper mental health treatment as well as proper care for those that are “prescription seeking” to gain access to medications to support substance abuse habits.
Are the medications you are prescribing doing what they are supposed to?
P&S Monitoring can remove the guesswork of prescribing medications. With the ability to track the impact that the medication has on a person’s autonomic nervous system, the provider can get the most accurate insight regarding the dosing and efficiency of the pharmaceutical to their patient’s condition and can also monitor for side effects that may not produce initial symptoms.
Maintaining a proper P&S balance optimizes the potential for proper weigh control.
Weight is a complicated issue. It is affected in many ways: genetic, mental, stress, GI function, exercise, diet, medications, lifestyle, hormones, etc. All of these ways also effect the P&S nervous systems. Granted some of these things cannot be changed or treated, like genetics, but perhaps the net resulting weight may only be modified. All of these ways also affect or are affected by the P&S nervous system. Simply put, more Sympathetic activity tends to lead to increased metabolism and weight loss, and more Parasympathetic activity tends to lead to decreased metabolism and weight gain.
P&S Monitoring can drastically alter the outcomes of a person’s head injury.
The Physio PS monitor can detect the slightest concussion, enabling the diagnosis without the presence of the telltale symptoms. This information can assist in determining the proper treatment and precautions to be implemented, increasing the likelihood of long-term health concerns, such as chronic traumatic encephalopathy, a degenerative brain disease, can be prevented.
Postural Orthostatic Tachycardia Syndrome (POTS)
There are more than 200,000 new cases of POTS in the U.S. each year, most commonly affecting women between the ages of 15 and 50.
Physio PS uses a patented algorithm that provides the only means of monitoring for P.O.T.S without a tilt table.
Physio PS Autonomic Monitoring is non-invasive and can be completed in under 20 minutes.
Ehlers-Danlos Syndrome (EDS)
While there is no cure for EDS, treatment and management for EDS is focused on preventing serious complications and symptom relief. The features of EDS vary by subtype, so management strategies can be slightly different, and due to the several body systems that may be affected, different medical specialists are usually involved in a patient’s care. The main aspects of management include cardiovascular (heart) work-up, physical therapy, pain management, and psychological follow-up as needed. The relief for those affected can be provided by balancing the autonomic nervous system.
THIS TECHNOLOGY SAVED MY LIFE….STEVE O’LEARY
‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.